Published in Br J Cancer on January 01, 1982
Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies. J Clin Oncol (2005) 1.06
Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all. Radiat Oncol (2015) 0.88
Miniature microwave applicator for murine bladder hyperthermia studies. Int J Hyperthermia (2012) 0.87
A soft agar colony assay for Lewis lung tumour and B16 melanoma taken directly from the mouse. Br J Cancer (1976) 3.42
Stem-cell survival and tumor control in the Lewis lung carcinoma. Cancer Res (1975) 3.04
Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea. Br J Cancer (1977) 2.31
Interaction of hyperthermia and the hypoxic cell sensitizer Ro-07-0582 on the EMT6 mouse tumour. Br J Cancer (1977) 1.90
Repopulation of gamma-irradiated Lewis lung carcinoma by malignant cells and host macrophage progenitors. Br J Cancer (1978) 1.77
Potential for therapy of drugs and hyperthermia. Cancer Res (1979) 1.37
Thermal enhancement of thio-TEPA cytotoxicity. J Natl Cancer Inst (1973) 1.33
Cell yield and cell survival following chemotherapy of the B16 melanoma. Br J Cancer (1978) 1.30
Interactions of hyperthermia and chemotherapy in animals. Cancer Res (1979) 1.15
Influence of anaesthetics on tumour-cell kill and repopulation in B16 melanoma treated with melphalan. Br J Cancer (1978) 1.09
Good thermal dosimetry is essential to good hyperthermia research. Br J Radiol (1978) 1.07
Thermometry considerations in localized hyperthermia. Med Phys (1978) 0.84
Improved immune-suppression techniques for the exongrafting of human tumours. Br J Cancer (1978) 4.28
The therapeutic response of three human tumor lines maintained in immune-suppressed mice. Cancer Res (1975) 3.50
Stem-cell survival and tumor control in the Lewis lung carcinoma. Cancer Res (1975) 3.04
Analysis of the cell population kinetics of transplanted tumours of widely-differing growth rate. Br J Cancer (1966) 2.88
In vitro and in vivo radiosensitivity of human tumour cells obtained from a pancreatic carcinoma xenograft. Nature (1976) 2.77
The growth kinetics of xenografts of human colorectal tumours in immune deprived mice. Br J Cancer (1975) 2.71
Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys (1979) 2.63
Cell proliferation studies in the intestinal epithelium of the rat. I. Determination of the kinetic parameters. Exp Cell Res (1965) 2.50
Cell loss as a factor in the growth rate of human tumours. Eur J Cancer (1967) 2.41
Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea. Br J Cancer (1977) 2.31
UKCCCR guidelines for the welfare of animals in experimental neoplasia. Lab Anim (1988) 1.95
Non-surgical management of early breast cancer in the United Kingdom: radiotherapy fractionation practices. Clinical Audit Sub-committee of the Faculty of Clinical Oncology, Royal College of Radiologists, and the Joint Council for Clinical Oncology. Clin Oncol (R Coll Radiol) (1995) 1.82
In vitro studies of cell proliferation in tumours. I. Critical appraisal of methods and theoretical considerations. Eur J Cancer (1965) 1.79
Variation in response of xenografts of colo-rectal carcinoma to chemotherapy. Br J Cancer (1978) 1.77
Repopulation of gamma-irradiated Lewis lung carcinoma by malignant cells and host macrophage progenitors. Br J Cancer (1978) 1.77
The growth and therapeutic response of human tumours in immune deficient mice. Bull Cancer (1978) 1.69
Cell proliferation studies in the intestinal epithelium of the rat. II. Theoretical aspects. Exp Cell Res (1965) 1.68
The radioresponsiveness of human tumours and the initial slope of the cell survival curve. Radiother Oncol (1984) 1.68
The human tumour xenograft--a valid model in experimental chemotherapy? Br J Surg (1980) 1.63
A comparison of methods for calculating DNA double-strand break induction frequency in mammalian cells by pulsed-field gel electrophoresis. Int J Radiat Biol (1994) 1.61
The response to chemotherapy of a variety of human tumour xenografts. Br J Cancer (1983) 1.53
The technique of labelled mitoses: analysis by automatic curve-fitting. Cell Tissue Kinet (1971) 1.51
Cell survival in B16 melanoma after treatment with combinations of cytotoxic agents: lack of potentiation. Br J Cancer (1977) 1.51
The growth rate of human tumours. Br J Cancer (1966) 1.49
The therapeutic response of bronchial carcinoma xenografts: a direct patient-xenograft comparison. Br J Cancer Suppl (1980) 1.44
Low-dose hyper-radiosensitivity: a consequence of ineffective cell cycle arrest of radiation-damaged G2-phase cells. Radiat Res (2004) 1.41
Quantitative techniques for study of the anatomy and function of small blood vessels in tumors. J Natl Cancer Inst (1969) 1.39
Expression of dose in neutron therapy. Radiother Oncol (1990) 1.38
The cell cycle in tumours: an examination of data gained by the technique of labelled mitoses. Cell Tissue Kinet (1972) 1.34
Influence of biogenic amines on the growth of xenografted human colorectal carcinomas. Br J Cancer (1979) 1.31
Cell yield and cell survival following chemotherapy of the B16 melanoma. Br J Cancer (1978) 1.30
The response of Chinese hamster V79 cells to low radiation doses: evidence of enhanced sensitivity of the whole cell population. Radiat Res (1993) 1.30
Growth kinetics of human large bowel cancer growing in immune-deprived mice and some chemotherapeutic observations. Cancer (1975) 1.28
Pharmacokinetics of nicotinamide and its effect on blood pressure, pulse and body temperature in normal human volunteers. Radiother Oncol (1992) 1.27
Influence of tumour size on hypoxic fraction and therapeutic sensitivity of Lewis lung tumour. Br J Cancer (1977) 1.24
Influence of tumour size on radiosensitization by misonidazole. Br J Cancer Suppl (1978) 1.24
Enhanced cell killing in lewis lung carcinoma and a human pancreatic-carcinoma xenograft by the combination of cytotoxic drugs and misonidazole. Br J Cancer (1981) 1.23
A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments. Radiother Oncol (1991) 1.18
Clinical evidence of hypersensitivity to low doses in radiotherapy. Radiother Oncol (1996) 1.17
Tumor size dependency in the radiation response of the Lewis lung carcinoma. Cancer Res (1975) 1.16
Delayed uptake by tumours of tritium from thymidine. Nature (1966) 1.16
Chemotherapy of human breast-carcinoma xenografts. Br J Cancer (1980) 1.15
Automated counting of mammalian cell colonies. Phys Med Biol (2001) 1.13
Low dose hypersensitivity in the T98G human glioblastoma cell line. Int J Radiat Biol (1999) 1.12
Low dose hyper-radiosensitivity and increased radioresistance in mammalian cells. Int J Radiat Biol (1997) 1.11
In vitro chemosensitivity tests on xenografted human melanomas. Br J Cancer (1980) 1.09
Dose-rate effects and the repair of radiation damage. Radiother Oncol (1986) 1.09
Influence of anaesthetics on tumour-cell kill and repopulation in B16 melanoma treated with melphalan. Br J Cancer (1978) 1.09
Human tumour xenografts: a critical appraisal. Br J Cancer Suppl (1980) 1.08
Low-dose hypersensitivity after fractionated low-dose irradiation in vitro. Int J Radiat Biol (2001) 1.07
Colony growth and clonogenic cell survival in human melanoma xenografts treated with chemotherapy. Br J Cancer (1980) 1.05
Role of apoptosis in low-dose hyper-radiosensitivity. Radiat Res (2007) 1.04
Combined radiotherapy--chemotherapy of Lewis lung carcinoma. Int J Radiat Oncol Biol Phys (1978) 1.04
The expression of early and late damage after thoracic irradiation: a comparison between CBA and C57B1 mice. Radiat Res (1983) 1.04
The growth and cell population kinetics of spontaneous tumours in domestic animals. Br J Cancer (1969) 1.04
Enhancement by cytotoxic agents of artificial pulmonary metastasis. Br J Cancer (1977) 1.03
Effect of environmental temperature on the kinetic properties of goldfish brain choline acetyltransferase. Biochem J (1972) 1.03
DNA strand break rejoining defect in xrs-6 is complemented by transfection with the human Ku80 gene. Cancer Res (1995) 1.03
Characterization of four new cell lines derived from human squamous carcinomas of the uterine cervix. Cancer Res (1987) 1.02
The response of human glioma cell lines to low-dose radiation exposure. Int J Radiat Biol (1999) 1.02
ZD1694 (Tomudex): a new thymidylate synthase inhibitor with activity in colorectal cancer. Eur J Cancer (1995) 1.02
Terminology in the description of drug-radiation interactions. Int J Radiat Oncol Biol Phys (1979) 1.02
Optimizing radiation-responsive gene promoters for radiogenetic cancer therapy. Gene Ther (2002) 1.02
Initial radiation-induced DNA damage in human tumour cell lines: a correlation with intrinsic cellular radiosensitivity. Br J Cancer (1994) 1.00
Cellular pharmacology and in vivo activity of a new anticancer agent, ZD9331: a water-soluble, nonpolyglutamatable, quinazoline-based inhibitor of thymidylate synthase. Clin Cancer Res (1997) 1.00
Influence of in vitro assay conditions on the assessment of radiobiological parameters of the MT tumour. Br J Radiol (1980) 0.97
Tumor growth and cell kinetics in chronically hypoxic animals. J Natl Cancer Inst (1970) 0.97
Relationship between radiation-induced low-dose hypersensitivity and the bystander effect. Radiat Res (2002) 0.97
Clonogenic assays in the B16 melanoma: response to cyclophosphamide. Br J Cancer (1977) 0.97
Assays of drug sensitivity for cells from human tumours: in vitro and in vivo tests on a xenografted tumour. Br J Cancer (1979) 0.96
An association between the radiation-induced arrest of G2-phase cells and low-dose hyper-radiosensitivity: a plausible underlying mechanism? Radiat Res (2003) 0.96
Induction and rejoining of DNA double-strand breaks in human cervix carcinoma cell lines of differing radiosensitivity. Radiat Res (1988) 0.96
Development of drug resistance in a murine mammary tumour. Br J Cancer (1985) 0.96
Hypersensitivity of a human tumour cell line to very low radiation doses. Int J Radiat Biol (1993) 0.95
Induced and inherent resistance to alkylating agents in human small-cell bronchial carcinoma xenografts. Br J Cancer (1984) 0.95
Size dependence of the response of Lewis lung tumors to BCNU. Cancer Treat Rep (1976) 0.95
A purpose-built iodine-125 irradiation plaque for low dose rate low energy irradiation of cell lines in vitro. Br J Radiol (2001) 0.95
Radiosensitivity, recovery and dose-rate effect in three human glioma cell lines. Radiother Oncol (1990) 0.95
Growth of fibroblasts as a potential confounding factor in soft agar clonogenic assays for tumour cell radiosensitivity. Radiother Oncol (1994) 0.94
Proceedings: Mechanism of action studies with IRCF 159: effects on the growth and morphology of BHK-21S cells. Br J Cancer (1974) 0.93
The comet moment as a measure of DNA damage in the comet assay. Int J Radiat Biol (1995) 0.92
Effect of serum starvation on expression and phosphorylation of PKC-alpha and p53 in V79 cells: implications for cell death. Int J Cancer (1999) 0.92
Evidence for the involvement of DNA-dependent protein kinase in the phenomena of low dose hyper-radiosensitivity and increased radioresistance. Int J Radiat Biol (2002) 0.91
Planned and unplanned gaps in radiotherapy: the importance of gap position and gap duration. Radiother Oncol (1994) 0.91
The effects of anesthetics and misonidazole on the development of radiation-induced lung damage in mice. Int J Radiat Oncol Biol Phys (1983) 0.90
Experimental combination and single-agent chemotherapy in human lung-tumour xenografts. Br J Cancer (1982) 0.90
Oxygen-dependent protection of radiation lung damage in mice by WR 2721. Int J Radiat Biol Relat Stud Phys Chem Med (1984) 0.90
Dose-rate effects in the radiation response of four human tumour xenografts. Radiother Oncol (1986) 0.90
Lung damage in C57B1 mice following thoracic irradiation: enhancement by chemotherapy. Br J Radiol (1979) 0.90
Hypersensitive response of normal human lung epithelial cells at low radiation doses. Int J Radiat Biol (1994) 0.90
Hypoxia- and radiation-activated Cre/loxP 'molecular switch' vectors for gene therapy of cancer. Gene Ther (2006) 0.90
The translational research chain: is it delivering the goods? Int J Radiat Oncol Biol Phys (2001) 0.90
Growth and radiosensitivity testing of human tumour cells using the adhesive tumour cell culture system. Br J Cancer (1990) 0.89
A novel human stress response-related gene with a potential role in induced radioresistance. Radiat Res (1999) 0.89
High intrinsic radiosensitivity of a newly established and characterised human embryonal rhabdomyosarcoma cell line. Br J Cancer (1989) 0.89
Might intrinsic radioresistance of human tumour cells be induced by radiation? Int J Radiat Biol (1996) 0.89